DexCom, Inc. vs VanEck Video Gaming and eSports ETF — how do they compare? DexCom, Inc. trades at $84.14 (market cap $31.86B), while VanEck Video Gaming and eSports ETF trades at $99.92 (market cap $248.06M). The key difference: DexCom, Inc. is far larger — about 128.4× VanEck Video Gaming and eSports ETF's market cap, and DexCom, Inc. is trading nearer its 52-week high, VanEck Video Gaming and eSports ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and VanEck Video Gaming and eSports ETF for 66 Days on average.
| DXCM | ESPO | |
|---|---|---|
Market Cap | $31.86B | $248.06M |
Volume | 3,607,070 | 13,622 |
Sector | Health | Sector/Thematic |
52-Week High | $92.34 | $118.68 |
52-Week Low | $54.84 | $85.25 |
Typical Hold Time | 62 Days | 66 Days |
Enterprise Value | $31.32B | — |
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.11, down 0.23% on the day, with a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $0.70, beating expectations, and has shown consistent revenue growth, with 2025 revenue reaching $4.66 billion and net income of $836.3 million. Analyst consensus is strongly bullish with an 80.77% buy rating and a $95.07 price target. Recent news highlights growth opportunities in Type 2 diabetes care and key executive promotions.
The outlook for DXCM is positive due to robust earnings beats, expanding market opportunities, and strong institutional support. However, risks include competitive pressures, reimbursement challenges, and a high valuation with a P/E of 33.38. The stock presents a growth opportunity but requires monitoring of execution against these risks.
ESPO trades at $97.32, down 0.33% on the day, with a bullish technical signal from moving averages and neutral oscillators. Key support is at $97 and resistance at $98. Financial ratios are unavailable in the provided data, limiting fundamental insight. No recent news is available to drive sentiment.
The outlook is mixed: technicals suggest upward momentum, but the absence of fundamental data and recent news creates uncertainty. Risks include market volatility and lack of visibility on financial health. Investors need updated earnings and guidance for a clearer investment case.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →